NPPB and hydrops fetalis: In addition, the inclusion of these amino acid levels in a multivariate model of clinical variables (including N-terminal proBNP levels) significantly improved its predictive capacity, highlighting the role of AAs as potential biomarkers for risk stratification in HF patients [34].